| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 616.30M | 601.10M | 570.90M | 500.20M | 262.80M | 368.90M |
| Gross Profit | 463.40M | 601.10M | 450.30M | 347.10M | 256.50M | 362.40M |
| EBITDA | 407.50M | 397.90M | 366.90M | 308.50M | 167.00M | 264.70M |
| Net Income | 293.90M | 282.60M | 256.90M | 233.90M | 127.80M | 205.10M |
Balance Sheet | ||||||
| Total Assets | 697.80M | 639.60M | 658.00M | 662.70M | 534.50M | 508.90M |
| Cash, Cash Equivalents and Short-Term Investments | 20.20M | 15.30M | 18.70M | 16.60M | 45.70M | 37.60M |
| Total Debt | 59.10M | 3.50M | 34.60M | 68.70M | 35.10M | 319.60M |
| Total Liabilities | 133.80M | 70.20M | 105.70M | 135.40M | 75.80M | 367.30M |
| Stockholders Equity | 564.00M | 569.40M | 552.30M | 527.30M | 458.70M | 141.60M |
Cash Flow | ||||||
| Free Cash Flow | 308.70M | 300.60M | 283.70M | 263.40M | 120.30M | 187.80M |
| Operating Cash Flow | 323.70M | 304.60M | 287.50M | 266.80M | 121.70M | 189.30M |
| Investing Cash Flow | -14.70M | 1.60M | 1.80M | -129.60M | -11.40M | -26.80M |
| Financing Cash Flow | -303.90M | -309.60M | -283.80M | -171.90M | -102.20M | -130.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £3.28B | 18.49 | 264.68% | 1.65% | 8.63% | 5.20% | |
70 Outperform | £3.87B | 11.42 | 51.86% | 1.81% | 3.95% | 7.68% | |
68 Neutral | £894.00M | 15.59 | 13.93% | 1.69% | 9.56% | 29.82% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |